IDEXX Laboratories, Inc.
DE ˙ XTRA ˙ US45168D1046
470,40 € ↓ -12,40 (-2,57%)
2026-06-03
AKTIENPREIS
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionVan Eck Associates Corp
Latest Disclosed Ownership26,710 shares
Latest Disclosed Value $ 15,008
Van Eck Associates Corp reports 3.03% increase in ownership of IX1 / IDEXX Laboratories, Inc.

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 26,710 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $13,034,480 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 25,925 shares of IDEXX Laboratories, Inc.. This represents a change in shares of 3.03% during the quarter. The current value of the position is $12,564,384 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IDEXX Laboratories COM 45168D104 26,710 785 3.03 15 -11.76 0.0098
2026-02-13 2025-12-31 13F IDEXX Laboratories COM 45168D104 25,925 1,824 7.57 18 13.33 0.0145
2025-11-13 2025-09-30 13F IDEXX Laboratories COM 45168D104 24,101 237 0.99 15 25.00 0.0143
2025-08-14 2025-06-30 13F IDEXX Laboratories COM 45168D104 23,864 -1,483 -5.85 13 20.00 0.0145
2025-05-15 2025-03-31 13F IDEXX Laboratories COM 45168D104 25,347 655 2.65 11 0.00 0.0138
2025-01-29 2024-12-31 13F IDEXX Laboratories COM 45168D104 24,692 -441 -1.75 10 -9.09 0.0131
2024-10-29 2024-09-30 13F IDEXX Laboratories COM 45168D104 25,133 2,367 10.40 12 0.00 0.0144
2024-07-31 2024-06-30 13F IDEXX Laboratories COM 45168D104 22,766 5,753 33.82 11 22.22 0.0158
2024-04-30 2024-03-31 13F IDEXX Laboratories COM 45168D104 17,013 720 4.42 9 0.00 0.0139
2024-02-05 2023-12-31 13F IDEXX Laboratories COM 45168D104 16,293 2,306 16.49 9 50.00 0.0165
2023-11-08 2023-09-30 13F IDEXX Laboratories COM 45168D104 13,987 276 2.01 6 0.00 0.0134
2023-08-03 2023-06-30 13F IDEXX Laboratories COM 45168D104 13,711 -1,547 -10.14 7 -14.29 0.0151
2023-05-03 2023-03-31 13F IDEXX Laboratories COM 45168D104 15,258 2,625 20.78 8 40.00 0.0174
2023-02-08 2022-12-31 13F IDEXX Laboratories COM 45168D104 12,633 -90 -0.71 5 -99.88 0.0133
2022-10-27 2022-09-30 13F IDEXX Laboratories COM 45168D104 12,723 737 6.15 4,145 -1.40 0.0123
2022-08-03 2022-06-30 13F IDEXX Laboratories COM 45168D104 11,986 -180,080 -93.76 4,204 -96.00 0.0111
2022-05-10 2022-03-31 13F IDEXX Laboratories COM 45168D104 192,066 59,810 45.22 105,071 20.65 0.2168
2022-01-26 2021-12-31 13F IDEXX Laboratories COM 45168D104 132,256 15,518 13.29 87,086 19.95 0.2015
2021-11-03 2021-09-30 13F IDEXX Laboratories COM 45168D104 116,738 -32,019 -21.52 72,600 -22.72 0.1825
2021-08-10 2021-06-30 13F IDEXX Laboratories COM 45168D104 148,757 -2,521 -1.67 93,947 26.92 0.2223
2021-05-13 2021-03-31 13F IDEXX Laboratories COM 45168D104 151,278 38,356 33.97 74,022 31.14 0.2014
2021-02-09 2020-12-31 13F IDEXX Laboratories COM 45168D104 112,922 5,275 4.90 56,447 33.39 0.1644
2020-12-04 2020-09-30 13F/A-1 IDEXX Laboratories COM 45168D104 107,647 -3,830 -3.44 42,317 14.97 0.1347
2020-11-12 2020-09-30 13F IDEXX Laboratories COM 45168D104 107,647 -3,830 42,317 131,197.6773
2020-08-14 2020-06-30 13F/A-1 IDEXX Laboratories COM 45168D104 111,477 -17,548 -13.60 36,806 17.76 0.1282
2020-08-10 2020-06-30 13F IDEXX Laboratories COM 45168D104 111,477 -17,548 36,806 125,039.2340
2020-05-12 2020-03-31 13F IDEXX Laboratories COM 45168D104 129,025 -11,267 -8.03 31,255 -14.68 0.1587
2020-02-13 2019-12-31 13F IDEXX Laboratories COM 45168D104 140,292 5,340 3.96 36,634 -0.17 0.1415
2019-11-08 2019-09-30 13F IDEXX Laboratories COM 45168D104 134,952 990 0.74 36,697 -0.51 0.1720
2019-08-07 2019-06-30 13F IDEXX Laboratories COM 45168D104 133,962 -42,549 -24.11 36,884 -6.55 0.1777
2019-05-13 2019-03-31 13F IDEXX Laboratories COM 45168D104 176,511 481 0.27 39,468 20.53 0.1939
2019-02-12 2018-12-31 13F IDEXX Laboratories COM 45168D104 176,030 3,654 2.12 32,745 -23.91 0.1642
2018-11-13 2018-09-30 13F IDEXX Laboratories COM 45168D104 172,376 -7,328 -4.08 43,035 9.88 0.2099
2018-08-13 2018-06-30 13F IDEXX Laboratories COM 45168D104 179,704 6,227 3.59 39,165 17.96 0.1831
2018-05-11 2018-03-31 13F IDEXX Laboratories COM 45168D104 173,477 13,630 8.53 33,202 32.82 0.1650
2018-02-12 2017-12-31 13F IDEXX Laboratories COM 45168D104 159,847 -2,503 -1.54 24,997 -0.98 0.1233
2017-11-09 2017-09-30 13F IDEXX Laboratories COM 45168D104 162,350 4,220 2.67 25,244 -1.10 0.1290
2017-08-11 2017-06-30 13F IDEXX Laboratories COM 45168D104 158,130 -4,268 -2.63 25,525 1.66 0.1395
2017-05-11 2017-03-31 13F IDEXX Laboratories COM 45168D104 162,398 -18,197 -10.08 25,108 18.56 0.1107
2017-02-09 2016-12-31 13F IDEXX Laboratories COM 45168D104 180,595 8,165 4.74 21,178 8.95 0.1055
2016-11-14 2016-09-30 13F IDEXX Laboratories COM 45168D104 172,430 -5,279 -2.97 19,438 17.79 0.0905
2016-08-12 2016-06-30 13F IDEXX Laboratories COM 45168D104 177,709 11,302 6.79 16,502 26.62 0.0846
2016-05-13 2016-03-31 13F IDEXX Laboratories COM 45168D104 166,407 -585 -0.35 13,033 7.03 0.0878
2016-02-12 2015-12-31 13F IDEXX Laboratories COM 45168D104 166,992 -30,465 -15.43 12,177 -16.94 0.0966
2015-11-12 2015-09-30 13F IDEXX Laboratories COM 45168D104 197,457 -47,622 -19.43 14,661 -6.73 0.1126
2015-08-12 2015-06-30 13F IDEXX Laboratories COM 45168D104 245,079 133,117 118.89 15,719 -9.12 0.0930
2015-05-14 2015-03-31 13F IDEXX Laboratories COM 45168D104 111,962 640 0.57 17,296 4.79 0.0999
2015-02-13 2014-12-31 13F IDEXX Laboratories COM 45168D104 111,322 -20,121 -15.31 16,506 6.57 0.1026
2014-11-14 2014-09-30 13F IDEXX Laboratories COM 45168D104 131,443 -29,149 -18.15 15,488 -27.79 0.0820
2014-08-14 2014-06-30 13F IDEXX Laboratories COM 45168D104 160,592 -48,992 -23.38 21,450 -15.69 0.0990
2014-05-08 2014-03-31 13F IDEXX LABS COM 45168D104 209,584 -192,527 -47.88 25,443 -40.52 0.1263
2014-02-12 2013-12-31 13F IDEXX LABS COM 45168D104 402,111 402,111 42,773 0.2160
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.